Covance Biotechnology Services Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Covance Biotechnology Services General Information

Description

Manufacturer of biopharmaceutical substance based in Princeton, New Jersey.

Contact Information

Formerly Known As
Corning Bio
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 210 Carnegie Center
  • Princeton, NJ 08540
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
AkzoNobel
Vertical(s)
Manufacturing
Corporate Office
  • 210 Carnegie Center
  • Princeton, NJ 08540
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covance Biotechnology Services Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covance Biotechnology Services‘s full profile, request access.

Request a free trial

Covance Biotechnology Services Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

Covance Biotechnology Services Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-6966992-B2 Purification of preferential particle from sample; obtain sample mixture, expose to chromatographic column, elute particle from column, recover particle Inactive 19-Mar-2001
US-20020183483-A1 Purification of preferential particle from sample; obtain sample mixture, expose to chromatographic column, elute particle from column, recover particle Active 19-Mar-2001
US-7229789-B1 Isolation of preferential proteins from cells; obtain cells, incubate with reducing agents and detergent, recover proteins Active 19-Jan-2001
US-7476726-B1 Employed for large scale recovery and purification; centrifugation of the broth from fermentation steps in recombinant production of endostatin protein is avoided, thereby preventing unwanted potential cellular lysis and potential contamination Inactive 14-Sep-1999
DE-60037886-D1 Process for the cleaning of recombinant proteins, which are growth hormone antagonists, by the aquatic two-phase extraction Inactive 07-May-1999 C07K14/61
To view Covance Biotechnology Services’s complete patent history, request access »

Covance Biotechnology Services Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covance Biotechnology Services‘s full profile, request access.

Request a free trial

Covance Biotechnology Services FAQs

  • When was Covance Biotechnology Services founded?

    Covance Biotechnology Services was founded in 1995.

  • Where is Covance Biotechnology Services headquartered?

    Covance Biotechnology Services is headquartered in Princeton, NJ.

  • What industry is Covance Biotechnology Services in?

    Covance Biotechnology Services’s primary industry is Pharmaceuticals.

  • Is Covance Biotechnology Services a private or public company?

    Covance Biotechnology Services is a Private company.

  • What is the current valuation of Covance Biotechnology Services?

    The current valuation of Covance Biotechnology Services is .

  • What is Covance Biotechnology Services’s current revenue?

    The current revenue for Covance Biotechnology Services is .

  • Who are Covance Biotechnology Services’s investors?

    Covance has invested in Covance Biotechnology Services.

  • When was Covance Biotechnology Services acquired?

    Covance Biotechnology Services was acquired on 15-Jun-2001.

  • Who acquired Covance Biotechnology Services?

    Covance Biotechnology Services was acquired by AkzoNobel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »